I still think they need to hire a real PR/Sales company once safety study is complete and phase 2 efficacy starts. These guys have some amazing science going, but majorily lack in communication to get the word out. The PR/Sales company would not be here to “ pump” the stock. But rather get more information out to shareholders and would be clients to sell their products.